Abstract
Background
Newly developed uncovered stents are designed to have varied radial force and high conformability to improve clinical outcome and safety. This study aimed to determine and compare the clinical outcome and safety of the Taewoong D-type uncovered stent and the Boston Scientific Wallfex stent.
Methods
Patients with acute malignant colonic obstruction were treated with a colonic stent. For the purpose of palliation, patients were randomly allocated. For the purpose of bridging, the type of stent was determined by the discretion of the individual doctors. Technical and clinical success and complication occurrence were measured as primary outcomes.
Results
From 12 university hospitals, 123 patients with malignant colonic obstruction were enrolled. Of these 123 patients, 58 were treated with colonic stents for palliative purposes. The technical and clinical success rate was 100 % for both stents in the palliative group. Perforation occurred for one patient (3.6 %) in the Wallflex stent group (n = 28) on day 5 and for no patients in the D-type stent group (n = 30). Two cases of migration occurred: one with the Wallflex stent and one with the D-type stent. Stent restenosis occurred for one patient with the Wallflex stent. Preoperative bridging stents were placed in 65 patients. The median time to surgery was 10 days. The technical success rate was 93.4 %, and clinical success was achieved for 86.2 % of the patients. Perforation occurred for five patients: four with the Wallflex stent and one with the D-type stent. The efficacy and safety of the two stents did not differ statistically.
Conclusions
The D-type colonic uncovered stent and the Wallflex colonic uncovered stent are effective and safe for both palliative and preoperative bridging therapy used to treat acute malignant colonic obstruction.
Similar content being viewed by others
References
Jemal A, Siegel R, Xu J et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300
Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
Dutton JW, Hreno A, Hampson LG (1976) Mortality and prognosis of obstructing carcinoma of the large bowel. Am J Surg 131:36–41
Barillari P, Aurello P, De Angelis R et al (1992) Management and survival of patients affected with obstructive colorectal cancer. Int Surg 77:251–255
Carraro PG, Segala M, Cesana BM et al (2001) Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery. Dis Colon Rectum 44:243–250
Cassidy J, Clarke S, Daz-Rubio E et al (2008) Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol 26:2006–2012
Kim JS, Hur H, Min BS et al (2009) Oncologic outcomes of self-expanding metallic stent insertion as a bridge to surgery in the management of left-sided colon cancer obstruction: comparison with nonobstructing elective surgery. World J Surg 33:1281–1286. doi:10.3748/wjg.v17.i28
Saltz LB, Clarke S, Daz-Rubio E et al (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 26:2013–2019
Andre T, Louvet C, Maindrault-Goebel F et al (1999) CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR. Eur J Cancer 35:1343–1347
Kabbinavar F, Hambleton J, Mass RD et al (2005) Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 23:3706–3712
Van Cutsem E, Twelves C, Cassidy J et al (2001) Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19:4097–4106
Tejero E, Mainar A, Fernndez L et al (1994) New procedure for the treatment of colorectal neoplastic obstructions. Dis Colon Rectum 37:1158–1159
Keen RR, Orsay CP (1992) Rectosigmoid stent for obstructing colonic neoplasms. Dis Colon Rectum 35:912–913
Vemulapalli R, Lara LF, Sreenarasimhaiah J et al (2010) A comparison of palliative stenting or emergent surgery for obstructing incurable colon cancer. Dig Dis Sci 55:1732–1737
Tilney HS, Lovegrove RE, Purkayastha S et al (2007) Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc 21:225–233
Repici A, Fregonese D, Costamagna G et al (2007) Ultraflex precision colonic stent placement for palliation of malignant colonic obstruction: a prospective multicenter study. Gastrointest Endosc 66:920–927
Bretagnol F, Panis Y, Rullier E et al (2010) Rectal cancer surgery with or without bowel preparation: the French GRECCAR III multicenter single-blinded randomized trial. Ann Surg 252:863–868
van Hooft JE, Fockens P, Marinelli AW et al (2008) Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy 40:184–191
Martinez-Santos C, Lobato RF, Fradejas JM et al (2002) Self-expandable stent before elective surgery vs emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary anastomosis and morbidity rates. Dis Colon Rectum 45:401–406
Watt AM, Faragher IG, Griffin TT et al (2007) Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg 246:24–30
Park S, Cheon JH, Park JJ et al (2010) Comparison of efficacies between stents for malignant colorectal obstruction: a randomized, prospective study. Gastrointest Endosc 72:304–310
Disclosures
Dae Young Cheung, Jin Yong Kim, Sung Pil Hong, Min Kyu Jung, Byong Duk Ye, Sang Gyun Kim, Jin Hong Kim, Kang Moon Lee, Kyung Ho Kim, Gwang Ho Baik, Ho Gak Kim, Chang Soo Eun, Tae Il Kim, Sang Woo Kim, Chang Duck Kim, and Chang Heon Yang have no conflicts of interests or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was conducted on behalf of the Korean Society of Gastrointestinal Endoscopy Stent Research Group. The members of this study group are listed in the appendix.
Appendix: Korean Society of Gastrointestinal Endoscopy Stent Research Group
Appendix: Korean Society of Gastrointestinal Endoscopy Stent Research Group
Dae Young Cheung, Jin Yong Kim, Sung Pil Hong, Min Kyu Jung, Byong Duk Ye, Sang Gyun Kim, Jin Hong Kim, Kang Moon Lee, Kyung Ho Kim, Gwang Ho Baik, Ho Gak Kim, Chang Soo Eun, Tae Il Kim, Sang Woo Kim, Young Soo Park, Jong Jae Park, Eun Taek Park, Chang Hwan Park, Ho June Song, Hoon Jai Chun, Young Deok Cho, Sang Woo Cha, Chang Duck Kim, and Chang Heon Yang.
Rights and permissions
About this article
Cite this article
Cheung, D.Y., Kim, J.Y., Hong, S.P. et al. Outcome and safety of self-expandable metallic stents for malignant colon obstruction: a Korean multicenter randomized prospective study. Surg Endosc 26, 3106–3113 (2012). https://doi.org/10.1007/s00464-012-2300-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-012-2300-x